Preferred Label : Bevacizumab/Lomustine Regimen;
NCIt synonyms : Lomustine/Bevacizumab; Bevacizumab/Lomustine; Lomustine/Bevacizumab Regimen; Bevacizumab-Lomustine; Lomustine-Bevacizumab;
NCIt related terms : Lomustine and Bevacizumab; Lomustine and Bevacizumab-adcd; Lomustine and Bevacizumab-awwb; Lomustine and Bevacizumab-aybi; Lomustine and Bevacizumab-maly; Lomustine and Bevacizumab-onbe; Lomustine and Bevacizumab-equi; Lomustine and Bevacizumab-bvzr;
NCIt definition : A regimen consisting of bevacizumab and lomustine that can be used for the treatment
of certain central nervous system (CNS) cancers including oligodendroglioma, astrocytoma,
glioblastoma (GBM) and gliosarcoma.;
NCI Metathesaurus CUI : CL969523;
Codes from synonyms : 47972; 127263; 127485; 127189; 127411; 127633; 127337; 127559;
Origin ID : C160526;
UMLS CUI : C5205330;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
